SCHEMBL24670338

SCHEMBL24670338

CCc1cnn2c(NCc3cccnc3)cc(N3CCCCC3CCOCCc3cn(S(=O)(=O)C4CC4)nn3)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 12/20 0.53
▸ GSK3B P49841 9/20 0.53
▸ CDK9 P50750 7/20 0.53
▸ CCNE1 P24864 6/20 0.53
▸ CDK5 Q00535 5/20 0.53
▸ CDK1 P06493 5/20 0.53
▸ CDK7 P50613 4/20 0.53
▸ CDK12 Q9NYV4 3/20 0.53
▸ GSK3A P49840 2/20 0.53
▸ TAOK1 Q7L7X3 2/20 0.53
▸ CCNT1 O60563 2/20 0.53
▸ CCNK O75909 2/20 0.53
▸ CCNH P51946 2/20 0.53
▸ MNAT1 P51948 2/20 0.53
▸ CDK13 Q14004 2/20 0.53
▸ CCNT2 O60583 1/20 0.53
▸ BRD4 O60885 1/20 0.53
▸ CCNB2 O95067 1/20 0.53
▸ CCNE2 O96020 1/20 0.53
▸ CDK4 P11802 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24667992 0.84 GSK3B (0.48) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL24670105 0.83 GSK3B (0.47) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL24669687 0.82 GSK3B (0.45) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL14346547 0.80 CDK2 (0.59) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL16198015 0.80 CDK2 (0.75) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL12953706 0.80 CDK2 (0.75) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL14389785 0.79 CDK2 (0.59) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL14364517 0.79 CDK2 (0.59) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL14346160 0.79 CDK2 (0.59) CDK2GSK3BCDK9CCNE1CDK5
SCHEMBL14364518 0.78 CDK2 (0.57) CDK2GSK3BCDK9CCNE1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 — — WO disclosed
Send feedback